CR

Coverage Rights

com.coverage-rights/coverage-rights

Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.

Yes, your AI can use this right now.Answered a live MCP handshake in 394 ms with no sign-in needed and exposes 9 tools.

Connect it

Settings → Connectors → Add custom connector
URL: https://www.coverage-rights.com/api/mcp

9 tools, verified live

Pulled straight from the server with tools/list on 2026-10-17.
list_insurersread-only

List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.

get_insurer_metricsread-only

Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.

rank_denial_ratesread-only

Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.

get_treatment_outcomesread-only

External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').

get_condition_outcomesread-only

External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.

search_outcomesread-only

Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.

get_appeal_rightsread-only

Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, TRICARE, and unknown coverage; unsupported or ambiguous routes fail closed.

get_drug_playbookread-only

Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that specific drug, what winning appeals argue, and the step-therapy exception framing — plus the publis

get_state_external_reviewread-only

How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.

Alternatives in Other

Compare →
Try “Notion”, “Stripe”, “create invoice”, “browser”